CATHETERRELATED INFECTIONS IN PEDIATRIC PATIENTS WITH CANCER

Tìm thấy 10,000 tài liệu liên quan tới từ khóa "CATHETERRELATED INFECTIONS IN PEDIATRIC PATIENTS WITH CANCER":

A survey of plasma IgA, IgG, IgM in pediatric patients with primary nephritic syndrome

A survey of plasma IgA, IgG, IgM in pediatric patients with primary nephritic syndrome

To survey plasma IgA, IgG and IgM concentrations and their association with some features in pediatric patients with primary nephritic syndrome. Subjects and methods: A cross-sectional study was performed on 94 subjects, including 61 children with primary nephrotic syndrome and 33 healthy controls.

Đọc thêm

A survey of plasma testosterone concentration in male patients with chronic kidney disease stage III - V

A SURVEY OF PLASMA TESTOSTERONE CONCENTRATION IN MALE PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE III - V

To evaluate the plasma testosterone level in male patients with chronic kidney disease stage III - V, pre-dialysis. Subjects and methods: A cross-sectional study with a study group of 118 chronic kidney disease patients, pre-dialysis.

7 Đọc thêm

NONINVASIVE VENTILATION

NON INVASIVE VENTILATION

with higher inspiratory concentration of CO2, which decreased at increasing flow rates [5].Similar findings were reported in a bench and healthy volunteers study with an increase ininspired concentration of CO2 when the gas flow rate was reduced below 30 l/min. It isnoteworthy t[r]

388 Đọc thêm

Evaluation of changes of dopamine plasma concentration in parkinson s disease patients

Evaluation of changes of dopamine plasma concentration in parkinson s disease patients

To investigate the alterations in plasma concentration of dopamine in patients with Parkinson’s disease. Subjects and methods: Changes in plasma concentration of dopamine were analyzed to find its correlations and clinical features in 45 patients with Parkinson’s disease (PD group) and 40 healthy pe[r]

Đọc thêm

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: A population-based study

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: A population-based study

In conclusion, PCa patients with a PSA level < 4 ng/ml have more favorable tumor characteristics at diagnosis and receive more benefit from active treatment. However, those patients with advanced TNM stage and high Gleason grade should be paid more attention in clinical application.

Đọc thêm

Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with

CLINICAL UTILITY OF POLYETHYLENE GLYCOL CONJUGATED GRANULOCYTE COLONY-STIMULATING FACTOR (PEG-G-CSF) FOR PREVENTING SEVERE NEUTROPENIA IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH

This study aimed to evaluate the efficacy and the safety of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing neutropenia in metastatic colorectal cancer (mCRC) patients that received fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus[r]

9 Đọc thêm

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

Gene networks and expression quantitative trait loci associated with adjuvant chemotherapy response in high-grade serous ovarian cancer

A major impediment in the treatment of ovarian cancer is the relapse of chemotherapy-resistant tumors, which occurs in approximately 25% of patients. A better understanding of the biological mechanisms underlying chemotherapy resistance will improve treatment efficacy through genetic testing and nov[r]

Đọc thêm

Pseudomonas aeruginosa in nosocomial infection: Burden in surgical site of tertiary care unit

PSEUDOMONAS AERUGINOSA IN NOSOCOMIAL INFECTION: BURDEN IN SURGICAL SITE OF TERTIARY CARE UNIT

Pseudomonas aeruginosa is a major cause of nosocomial infections. It has natural resistance as well as acquired multidrug resistance to various antibiotics leading to increased morbidity and mortality which lead to problematic condition. The main aim is to study the resistance pattern of Pseudomonas[r]

5 Đọc thêm

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

TUMOR ENDOTHELIAL ELTD1 AS A PREDICTIVE MARKER FOR TREATMENT OF RENAL CANCER PATIENTS WITH SUNITINIB

Patients with metastatic renal cell cancer (mRCC) are commonly treated with the tyrosine kinase inhibitor sunitinib, which blocks signalling from vascular endothelial growth factor (VEGF) - and platelet-derived growth factor-receptors, inhibiting development of new blood vessels.

8 Đọc thêm

Sensitive detection methods are key to identify secondary EGFR c.2369C&gt;T p.(Thr790Met) in non-small cell lung cancer tissue samples

Sensitive detection methods are key to identify secondary EGFR c.2369C&gt;T p.(Thr790Met) in non-small cell lung cancer tissue samples

Correct identification of the EGFR c.2369C>T p.(Thr790Met) variant is key to decide on a targeted therapeutic strategy for patients with acquired EGFR TKI resistance in non-small cell lung cancer. The aim of this study was to evaluate the correct detection of this variant in 12 tumor tissue specimen[r]

Đọc thêm

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

EGFR mutation testing and treatment decisions in patients progressing on firstor second-generation epidermal growth factor receptor tyrosine kinase inhibitors

The objective of this study was to investigate real-world EGFR mutation testing in patients with metastatic non-small cell lung cancer (NSCLC) upon progression on first−/second-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI), and subsequent treatments received.

Đọc thêm

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced nonsmall cell lung cancer: A meta-analysis

The prognostic significance of TP53 concurrent mutations in patients with epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)- mutated advanced non–small-cell lung cancer (NSCLC) who received EGFR-tyrosine kinase inhibitors (TKIs) or ALK-TKIs based targeted therapy remains c[r]

Đọc thêm

SIP SMART: A parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer

SIP SMART: A PARALLEL GROUP RANDOMISED FEASIBILITY TRIAL OF A TAILORED PRE-TREATMENT SWALLOWING INTERVENTION PACKAGE COMPARED WITH USUAL CARE FOR PATIENTS WITH HEAD AND NECK CANCER

Dysphagia or difficulty in swallowing affects quality of life for most patients with head and neck cancer. SIP SMART – [Swallowing Intervention Package: Self-Monitoring, Assessment, Rehabilitation Training] aims to improve post-treatment swallowing outcomes through a targeted and tailored pre-treatm[r]

13 Đọc thêm

Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells

MODULATION OF SIRT3 EXPRESSION THROUGH CDK4/6 ENHANCES THE ANTI-CANCER EFFECT OF SORAFENIB IN HEPATOCELLULAR CARCINOMA CELLS

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients with HCC show reduced sensitivity to sorafenib during treatment.

15 Đọc thêm

NGHIÊN CỨU KẾT QUẢ SÀNG LỌC PHÁT HIỆN UNG THƯ PHỔI Ở ĐỐI TƯỢNG TRÊN 60 TUỔI CÓ YẾU TỐ NGUY CƠ BẰNG CHỤP CẮT LỚP VI TÍNH LIỀU THẤP (TT ANH)

NGHIÊN CỨU KẾT QUẢ SÀNG LỌC PHÁT HIỆN UNG THƯ PHỔI Ở ĐỐI TƯỢNG TRÊN 60 TUỔI CÓ YẾU TỐ NGUY CƠ BẰNG CHỤP CẮT LỚP VI TÍNH LIỀU THẤP (TT ANH)

INTRODUCTION OF THESIS

1. Background:
Lung cancer is one of the common cancers. The disease has the highest incidence and mortality among cancers, most commonly seen in the elderly especially over 60 years old. The majority of lung cancer is related to secondhand and passive smoking and has over[r]

Đọc thêm

All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells

ALL-TRANS RETINOIC ACID REDUCES CANCER STEM CELL-LIKE CELL-MEDIATED RESISTANCE TO GEFITINIB IN NSCLC ADENOCARCINOMA CELLS

The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH[r]

9 Đọc thêm

Ebook Nelson’s pediatric antimicrobial therapy (20th edition) Part 2

EBOOK NELSON’S PEDIATRIC ANTIMICROBIAL THERAPY (20TH EDITION) PART 2

(BQ) Part 2 book Nelson’s pediatric antimicrobial therapy presentation of content: Preferred therapy for specific parasitic pathogens, alphabetic listing of antimicrobials, antibiotic therapy for obese children, antibiotic therapy for patients with renal failure, adverse reactions to antimicrobial a[r]

136 Đọc thêm

Cardiovascular disease events within 5 years after a diagnosis of breast cancer

Cardiovascular disease events within 5 years after a diagnosis of breast cancer

Concern for cardiovascular disease (particularly atrial fibrillation-AF) among women with breast cancer is becoming a major issue. We aimed at determining the incidence of cardiovascular disease events (AF, arterial and cardiac events, venous-thromboembolism-VTE) in patients diagnosed with breast ca[r]

Đọc thêm

Metastasis-directed therapy in castrationrefractory prostate cancer (MEDCARE): A non-randomized phase 2 trial

Metastasis-directed therapy in castrationrefractory prostate cancer (MEDCARE): A non-randomized phase 2 trial

: Patients diagnosed with metastatic castration-refractory prostate cancer (mCRPC) rely on a limited number of therapeutic agents resulting in a median survival of 2–3 years. A subgroup of those patients with mCRPC presents with oligoprogressive disease.

Đọc thêm

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

In this retrospective study, we evaluated the biochemical recurrence rate, metastatic disease progression, and prostate cancer-specific and overall survival in patients curatively treated with external beam radiotherapy (EBRT) for early prostate cancer (PC).

Đọc thêm

Cùng chủ đề